Regional Health Properties Reports Third Quarter 2023 Financial Results
Collected 93% of Contractual Rent Strong Operator Rent Coverage ATLANTA, GA, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Regional Health Properties,...
COVID-19
Global COVID-19 Monument Design Competition Winner Announced
These Frontline workers deserve a monument, Please donate $10 to honor them today! Casey Schachner COVID-19 Monument Design Contest winner...
Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer
Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023...
UpHealth Enters into Definitive Agreement for Sale of Cloudbreak Health Business to GTCR for $180 Million
Proceeds Will be Utilized to Pay Down All Unsecured Debt and Approximately 45% of Secured Debt UpHealth Will Focus on...
LCF Georgia Releases Groundbreaking Status of Latino Health Report in Georgia
The Last Report of Its Kind Was Issued a Decade AgoATLANTA, GA / ACCESSWIRE / November 16, 2023 / A...
Gratia Health Emerges From Stealth With ScionHealth Partnership to Support Frontline Caregivers With Its Incentive Compensation Platform
Now live at 70-plus hospitals nationwide, Gratia has supported employees while helping health system reduce contract nursing labor costsAUSTIN, Texas--(BUSINESS...
Inhalon Biopharma Secures U.S. Army Medical Research and Development Command Award to Support Development of Inhaled Therapeutics for Treatment of COVID-19
U.S. Army-Funded Project Will Support Further Development of Novel Therapeutic ModalityDURHAM, N.C.--(BUSINESS WIRE)--Inhalon Biopharma, a clinical-stage company advancing a proprietary...
FSD Pharma Files Supplement to Management Information Circular in Connection with Special Meeting to be Held on November 20, 2023
TORONTO, ON / ACCESSWIRE / November 15, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical...
City Trees Announces New Market Venture in New Mexico Through Licensing Agreement.
LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), (the ''Company'' or ''CLS''), a...
NanoViricides Has Filed its Quarterly Report – NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
SHELTON, CT / ACCESSWIRE / November 15, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed...
Awakn Life Sciences Receives Regulatory and Ethical Approval for Phase III Clinical Trial of AWKN-P001
AWKN-P001 is a N-methyl-D-aspartate Receptor-Modulating Drug Used in Combination with Psycho-Social Support for the Treatment of Severe Alcohol Use DisorderToronto,...
Humanetics Corporation Appoints Dr. Colin Chinn as Chief Medical Officer
Dr. Chinn retired as a Rear Admiral of the United States NavyMINNEAPOLIS--(BUSINESS WIRE)--Humanetics Corporation, a leading innovator in medical countermeasures,...
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update
The Company's ALG.APV-527 Phase 1 Trial for the Treatment of Multiple Solid Tumors Continues to ProgressPlanning for APVO436 Phase 2...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business UpdateEnrollment completed for...
Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023
CAMBRIDGE, MA / ACCESSWIRE / November 14, 2023 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host its second...
Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development
SHELTON, CT / ACCESSWIRE / November 14, 2023 / NanoViricides, Inc. (AMEX:NNVC) (the "Company"), a leader in the development of...
United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTI
The Company Will Submit for FDA Orange-Book Listing in the Near TermSOLANA BEACH, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) --...
ReWalk Robotics Reports Third Quarter 2023 Financial Results
Record Quarterly Revenue of $4.4 Million Successful Completion of AlterG Acquisition and Significant Progress of Integration Major Advancement in Efforts...
IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference...
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create...